Condition: Spondyloarthritis · Ruminococcus Gnavus · Sponsor: Assistance Publique - Hôpitaux de Paris
The primary objective of this case-control study aims to explore the role of bacterium Ruminococcus gnavus (R. gnavus) with intestinal biopsy and faecal sampling in the initiation and the development of spondyloarthritis (SPA) in comparison with health control subjets (patients without chronic disease but have indication to digestive endoscopy).
This description comes directly from the study's public registry record.
Maxime BREBAN, MD, PhD · +33 1 49 09 56 72 · maxime.breban@aphp.fr
Always discuss trial participation with your own doctor first.
| Service de Rhumatologie, Hôpital Ambroise Paré, APHP | Boulogne-Billancourt, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04853212